A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.

A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.

Japanese encephalitis virus (JEV), a mosquito-borne flavivirus that causes fatal neurological disease in humans, is one of the most important emerging pathogens of public health significance. JEV represents the JE serogroup, which also includes West Nile, Murray Valley encephalitis, and St. Louis en...

Full description

Bibliographic Details
Main Authors:	Sang-Im Yun, Byung-Hak Song, Jin-Kyoung Kim, Gil-Nam Yun, Eun-Young Lee, Long Li, Richard J Kuhn, Michael G Rossmann, John D Morrey, Young-Min Lee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-07-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC4117607?pdf=render

Similar Items

Correction: A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA-14-2 Virus: A Conserved Single Amino Acid in the Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice.
Published: (2014-09-01)

Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
by: Jian Yang, et al.
Published: (2017-01-01)

Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India
by: Mayilsamy Muniaraj, et al.
Published: (2019-04-01)

Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus
by: Paridhi Gupta, et al.
Published: (2017-04-01)

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism
by: Xinyu Liu, et al.
Published: (2018-05-01)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
by: Mya Myat Ngwe Tun, et al.
Published: (2021-05-01)

Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone
by: Guohua Li, et al.
Published: (2021-06-01)

Effectiveness of Japanese encephalitis vaccine SA 14-14-2 and impact of immunization among adults in Assam, India
by: S.A. Khan, et al.
Published: (2020-12-01)

Molecular determinants of mouse neurovirulence and mosquito infection for Western equine encephalitis virus.
by: Eric C Mossel, et al.
Published: (2013-01-01)

Use of the live attenuated Japanese Encephalitis vaccine SA 14–14–2 in children: A review of safety and tolerability studies
by: Amy Sarah Ginsburg, et al.
Published: (2017-10-01)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
by: Susan L Hills, et al.
Published: (2022-01-01)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.
by: Shyam Raj Upreti, et al.
Published: (2017-09-01)

The interaction between the Marek’s Disease Virus (MDV) neurovirulence factor pp14 and the host transcription factor, CREB3
by: Sabaratnam, K
Published: (2017)

Evolution of neurovirulent Zika virus
by: Screaton, G, et al.
Published: (2017)

Characterization of nonstructural protein 3 of a neurovirulent Japanese encephalitis virus strain isolated from a pig
by: Wei Jianchao, et al.
Published: (2011-05-01)

Cellular immune responses to live attenuated Japanese Encephalitis (JE) vaccine SA14-14-2 in adults in a JE/dengue co-endemic area.
by: Turtle, L, et al.
Published: (2017)

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
by: Lance Turtle, et al.
Published: (2017-01-01)

Polyomavirus Wakes Up and Chooses Neurovirulence
by: Arrienne B. Butic, et al.
Published: (2023-10-01)

Letter to the editor of IJS.
by: Dev, H, et al.
Published: (2010)

Il progetto IJ
by: Simone Zurli
Published: (2020-12-01)

Studies on bone matrix glycoproteins. Incorporation of (1-14C)glucosamine and plasma (14C)glycoprotein into rabbit cortical bone.
by: Triffitt, J, et al.
Published: (1973)

Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence
by: Ayano Fukui, et al.
Published: (2023-08-01)

1,4-Dideoxy-1,4-imino-D-mannitol inhibits glycoprotein processing and mannosidase.
by: Palamarczyk, G, et al.
Published: (1985)

Antibody escape by polyomavirus capsid mutation facilitates neurovirulence
by: Matthew D Lauver, et al.
Published: (2020-09-01)

ANALYSIS OF DOMAIN SPECIFICITY OF THE PROTECTIVE CHIMERIC ANTIBODY ch14D5a AGAINST GLYCOPROTEIN E OF TICK-BORNE ENCEPHALITIS VIRUS
by: I. K. Baykov, et al.
Published: (2018-07-01)

NEDERLANDS INSTITUUT V2IJ
by: J. L. Mey
Published: (1954-11-01)

Cleavage of a Neuroinvasive Human Respiratory Virus Spike Glycoprotein by Proprotein Convertases Modulates Neurovirulence and Virus Spread within the Central Nervous System.
by: Alain Le Coupanec, et al.
Published: (2015-01-01)

The Mutation of the Genes Related to Neurovirulence in HSV-2 Produces an Attenuated Phenotype in Mice
by: Lei Liu, et al.
Published: (2020-07-01)

Live Viral Vaccine Neurovirulence Screening: Current and Future Models
by: Corey May Fulton, et al.
Published: (2021-06-01)

T cell deficiency precipitates antibody evasion and emergence of neurovirulent polyomavirus
by: Matthew D Lauver, et al.
Published: (2022-11-01)

Correction to: Differential neurovirulence of Usutu viruslineages in mice and neuronal cells
by: Marion Clé, et al.
Published: (2021-02-01)

CLONING, EXPRESSION, AND CHARACTERIZATION OF AN ALKALOPHILLIC ENDO-1,4-BETA-XYLANASE FROM PAENIBACILLUS SP. HPL-002
by: No-Joong Park,, et al.
Published: (2011-12-01)

IS-98-ST1 West Nile virus derived from an infectious cDNA clone retains neuroinvasiveness and neurovirulence properties of the original virus.
by: Céline Bahuon, et al.
Published: (2012-01-01)

The Ij-plein: Housing At The Threshold of Urban Policies
by: Esen Gökçe Özdamar
Published: (2015-11-01)

Mice as an Animal Model for Japanese Encephalitis Virus Research: Mouse Susceptibility, Infection Route, and Viral Pathogenesis
by: Jordan C. Frank, et al.
Published: (2023-05-01)

Profiling of viral proteins expressed from the genomic RNA of Japanese encephalitis virus using a panel of 15 region-specific polyclonal rabbit antisera: implications for viral gene expression.
by: Jin-Kyoung Kim, et al.
Published: (2015-01-01)

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
by: K. Zaman, et al.
Published: (2022-04-01)

Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.
by: Lester M Shulman, et al.
Published: (2006-01-01)

Cloning, Expression and Characterization of a Thermostable Esterase HydS14 from Actinomadura sp. Strain S14 in Pichia pastoris
by: Pichapak Sriyapai, et al.
Published: (2015-06-01)

Effects of the alpha-mannosidase inhibitors, 1,4-dideoxy-1,4-imino-D-mannitol and swainsonine, on glycoprotein catabolism in cultured macrophages.
by: Daniel, P, et al.
Published: (1989)